MARA Holdings
MARA
Ecopetrol
EC
Oracle
ORCL
Apple
AAPL
Coinbase
COIN
US Stock MarketDetailed Quotes
DNTH Dianthus Therapeutics
- 24.030
- +0.510+2.17%
Close Mar 7 16:00 ET
- 24.030
- 0.0000.00%
Post 16:00 ET
711.22MMarket Cap-10.52P/E (TTM)
24.805High22.280Low205.31KVolume23.710Open23.520Pre Close4.94MTurnover1.59%Turnover RatioLossP/E (Static)29.60MShares33.77052wk High2.10P/B311.33MFloat Cap18.13052wk Low--Dividend TTM12.96MShs Float336.000Historical High--Div YieldTTM10.74%Amplitude5.136Historical Low24.051Avg Price1Lot Size
About Dianthus Therapeutics Company
Dianthus Therapeutics, Inc. is a clinical-stage biotechnology company. It designs and delivers novel, monoclonal antibodies with improved selectivity and potency over existing complement therapies. The company was founded on June 17, 2015 and is headquartered in New York, NY.
Company Profile
SymbolDNTH
Company NameDianthus Therapeutics
Listing DateJun 21, 2018
Founded2015
CEOMr. Marino Garcia
MarketNASDAQ
Employees53
Fiscal Year Ends12-31
Address7 Times Square,43rd Floor
CityNew York
ProvinceNew York
CountryUnited States of America
Zip Code10036
Phone1-929-999-4055
Websitehttp://dianthustx.com
Company Executives
- Name
- Position
- Salary
- Marino Garcia
- President, Chief Executive Officer and Director
- --
- Edward G. Carr
- Chief Accounting Officer
- --
- Dr. Simrat Randhawa, M.D.
- Chief Medical Officer
- --
- Ryan Savitz
- Chief Financial Officer, Chief Business Officer and Treasurer
- --
- Adam M. Veness
- Senior Vice President, General Counsel and Secretary
- --
- Leon O. Moulder, Jr
- Chairman of the Board
- --
- Dr. Jonathan Violin, M.B.A.,PhD
- Director
- --
- Sujay R. Kango
- Director
- --
- Dr. Steven Joseph Romano, M.D.
- Director
- --
- Anne M. McGeorge
- Independent Director
- --
- Alison F. Lawton
- Independent Director
- --
- Paula Soteropoulos
- Independent Director
- --
Trending Stocks
Fed Rate Cut Beneficiaries Fed Rate Cut Beneficiaries
Stocks that are expected to benefit from a Federal Reserve rate cut. Information is provided by Futu and is a non-exhaustive list of all thematic stocks for reference purposes only.
This section presents the top 5 stocks in Fed Rate Cut Beneficiaries, ranked from highest to lowest based on real-time market data. Stocks that are expected to benefit from a Federal Reserve rate cut. Information is provided by Futu and is a non-exhaustive list of all thematic stocks for reference purposes only.
This section presents the top 5 stocks in Fed Rate Cut Beneficiaries, ranked from highest to lowest based on real-time market data.